Bioenergetic profiles of peripheral mononuclear cells and systemic inflammation in women with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)

被引:1
|
作者
Kumar, Parveen [1 ]
Oster, Robert A. [2 ]
Assimos, Dean G. [1 ]
Ness, Timothy J. [3 ]
Mitchell, Tanecia [1 ]
机构
[1] Univ Alabama Birmingham, Dept Urol, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Med, Birmingham, AL USA
[3] Univ Alabama Birmingham, Dept Anesthesiol, Birmingham, AL USA
来源
PLOS ONE | 2024年 / 19卷 / 02期
关键词
MITOCHONDRIAL; PREVALENCE; BIOMARKERS; MONOCYTES; PLATELETS; MARKERS; HEALTH;
D O I
10.1371/journal.pone.0298981
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Inflammation is thought to contribute to the etiology of interstitial cystitis/bladder pain syndrome (IC/BPS). It is well-known that disruption in metabolism in immune cells contributes to inflammation in several inflammatory diseases. The purpose of this study was to investigate whether cellular bioenergetics is altered in monocytes and lymphocytes from women with IC/BPS, and if these alterations correlate with systemic inflammatory markers. Age and BMI matched adult healthy women (HS; n = 18) and women with IC/BPS (n = 18) were included in the study. Blood was collected to assess cellular bioenergetics in monocytes and lymphocytes using a Seahorse XF96 Analyzer and plasma cytokine levels were measured using Meso Scale Discovery immunoassays. The correlation between bioenergetic parameters, cytokines, and demographics was determined using Pearson correlation coefficients. Means of the two groups were compared using the two-group t-test. Patients with IC/BPS had reduced monocyte oxygen consumption rates and glycolytic rates compared to healthy subjects. In contrast, lymphocytes from these patients had increased oxygen consumption rates and glycolytic rates. Several cytokines and chemokines including Interferon-gamma (IFN-gamma), tumor necrosis factor alpha (TNF-alpha), Interleukin-6 (IL-6), Interleukin-8 (IL-8) and vascular endothelial growth factor (VEGF) levels were significantly elevated in the plasma of patients with IC/BPS. However, Transforming growth factor (TGF-beta) and Interleukin-10 (IL-10) levels were significantly decreased in IC/BPS patients compared to HS. In addition, Interferon gamma (IFN-gamma), TNF-alpha, IL-8, and TGF-beta levels correlated with several bioenergetic parameters in monocytes or lymphocytes from healthy subjects. In contrast, TNF-alpha and IL-8 correlated with bioenergetic parameters in monocytes from IC/BPS patients. Monocyte and lymphocyte cellular bioenergetics and plasma cytokine levels are different in patients with IC/PBS compared to HS. It appears that systemic inflammation is greater in this cohort which may negatively impact immune cell function. The relationship between cellular bioenergetics and inflammation in monocytes and lymphocytes could be important in understanding the pathogenesis of IC/PBS and warrants further investigation.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Interstitial cystitis/bladder pain syndrome (IC/BPS)
    Vahlensieck, Winfried
    UROLOGIE, 2023, 62 (06): : 582 - 589
  • [2] Interstitial cystitis/bladder pain syndrome (IC/BPS)
    Bschleipfer, Thomas
    UROLOGE, 2020, 59 (09): : 1123 - 1134
  • [3] Interstitielle Zystitis/Blasenschmerzsyndrom (IC/BPS)Interstitial cystitis/bladder pain syndrome (IC/BPS)
    Winfried Vahlensieck
    Die Urologie, 2023, 62 (6) : 582 - 589
  • [4] Hydrodistention of the bladder for the treatment of bladder pain syndrome/interstitial cystitis (BPS/IC)
    Hoke, Tanya P.
    Goldstein, Howard
    Saks, Emily K.
    Vakili, Babak
    NEUROUROLOGY AND URODYNAMICS, 2017, 36 (03) : 784 - 786
  • [5] Rehabilitation of patients with interstitial cystitis/bladder pain syndrome (IC/BPS)
    Vahlensieck, Winfried
    El Idrissi, Raschid
    Gerhard-Franke, Ursula
    Huber, Maren
    Jenner, Jennifer
    Zermann, Dirk-Henrik
    AKTUELLE UROLOGIE, 2021, 52 (06) : 575 - 582
  • [6] Investigational drugs for bladder pain syndrome (BPS)/interstitial cystitis (IC)
    Chuang, Yao-Chi
    Chermansky, Christopher
    Kashyap, Mahendra
    Tyagi, Pradeep
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (05) : 521 - 529
  • [7] Current and emerging drugs for interstitial cystitis/bladder pain syndrome (IC/BPS)
    Ogawa, Teruyuki
    Ishizuka, Osamu
    Ueda, Tomohiro
    Tyagi, Pradeep
    Chancellor, Michael B.
    Yoshimura, Naoki
    EXPERT OPINION ON EMERGING DRUGS, 2015, 20 (04) : 555 - 570
  • [8] THE MICROBIOME OF HUNNER LESIONS IN INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME (IC/BPS)
    Nickel, J. Curtis
    Erhlich, Garth
    Doiron, R. Christopher
    Kelly, Kerri-Lynn
    Earl, Joshua
    JOURNAL OF UROLOGY, 2020, 203 : E1163 - E1164
  • [9] Intravesical tacrolimus in intractable bladder pain syndrome/interstitial cystitis (BPS/IC)
    Mishra, Nagendra Nath
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 : 84 - 84
  • [10] Advances in intravesical therapy for bladder pain syndrome (BPS)/interstitial cystitis (IC)
    Meng, En
    Hsu, Yu-Chao
    Chuang, Yao-Chi
    LUTS-LOWER URINARY TRACT SYMPTOMS, 2018, 10 (01) : 3 - 11